Results 71 to 80 of about 10,548 (182)

Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Myocardial fibrosis is prevalent in cardiomyopathies that result in heart failure with reduced ejection fraction. Heart failure with reduced ejection fraction treated with a left ventricular assist device (LVAD) yields hemodynamic unloading ...
Rachel M. Biggs, Yuhua Zhang, Daniel N. Silverman, Catalin F. Baicu, An O. Van Laer, Lauren Wakefield, Devki Bhatt, Stephanie Masline, Lily S. Neff, Arman Kilic, Lucas J. Witer, Brian A. Houston, Samuel J. Coeyman, William J. Richardson, Michael R. Zile, Amy D. Bradshaw   +15 more
doaj   +1 more source

How Formal and Informal Nurse Leaders Enact Shared Implementation Leadership in a Hospital Setting

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To describe how implementation leadership manifests among formal and informal point of care nurse leaders during a successful evidence‐based practice implementation. Design A collective case study. Methods A conceptual framework on shared implementation leadership guided the study. Two units known for strong implementation were selected as
Sonia Angela Castiglione, Mélanie Lavoie‐Tremblay, Kelley Kilpatrick, Wendy Gifford, Sonia Elizabeth Semenic   +4 more
wiley   +1 more source

Patients Experiencing Unsuccessful Defibrillation From Implantable Cardiac Devices Remain at Elevated Risk Despite Procedural Management

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Unsuccessful defibrillation therapy in patients with implantable cardiac defibrillators (ICDs) and ventricular tachytherapies may occur due to patient and/or device‐related factors; appropriate management strategies after failed defibrillation therapy have been incompletely described.
Nathaniel Christian‐Miller, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Jackson Liang, Ryan Cunnane, Krit Jongnarangsin, Frank Pelosi, Hakan Oral, Michael Ghannam   +9 more
wiley   +1 more source

Nocturnal Hypoxemic Burden Predicts Mortality in Patients Awaiting Heart Transplantation

Journal of Sleep Research, EarlyView.
Trial design and results on hypoxemic burden in the context of heart transplantation. ABSTRACT Risk stratification for patients with end‐stage heart failure (HF) awaiting heart transplantation (HTX) is crucial. Sleep‐disordered breathing (SDB) is a prevalent comorbidity, yet the impact of its resultant hypoxemic burden remains unclear in this ...
Max Potratz, Tatevik Manukyan, René Schramm, Angelika Costard‐Jäckle, Uwe Fuchs, Michiel Morshuis, Sabina P. W. Guenther, Sebastian V. Rojas, Volker Rudolph, Jan F. Gummert, Henrik Fox   +10 more
wiley   +1 more source

Incidence and Determinants of Implantable Cardioverter‐Defibrillator Therapy With Loss of and Impaired Consciousness

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Implantable cardioverter‐defibrillators (ICDs) are important in the prevention of sudden cardiac death. However, some appropriate ICD therapies may be considered unnecessary, delivered when patients do not experience symptoms of hemodynamic instability such as loss of consciousness.
Alwin B. P. Noordman, Michiel Rienstra, Yuri Blaauw, Bart A. Mulder, Hessel Groenveld, Alexander H. Maass   +5 more
wiley   +1 more source

The approach to placement of a continuous-flow intracorporeal ventricular assist device in small left ventricle

JHLT Open
Background: The HeartMate 3 (HM3) has become among the most widely utilized durable left ventricular (LV) assist devices (LVAD) owing to reduced rates of pump thrombosis, bleeding, and stroke.
Ryaan EL-Andari, MD, Josiane Dion, MD, Jennifer Conway, MD, MSc, Tara Pidborochynski, MSc, Lindsey Carter, MD, Gurmeet Singh, MD, MSc, Roderick MacArthur, MD, MSc, Steven Meyer, MD, PhD, Devilliers Jonker, MD, Darren H. Freed, MD, PhD, Holger Buchholz, MD   +10 more
doaj   +1 more source

Long‐Term Outcomes of Radiofrequency Atrioventricular Node Ablation in a Real‐World Population

Pacing and Clinical Electrophysiology, EarlyView.
Abstract Background While interventional strategies have expanded the options for long term rhythm restoration, rate control continues to play a pivotal role in the treatment of atrial arrhythmias; however, pharmacologic strategies alone often fail in achieving effective rate control.
Vanessa Sciacca, Nora‐Kristin Brandt, Thomas Fink, Denise Guckel, Maximilian Mörsdorf, Yuri Bocchini, Martin Braun, Moneeb Khalaph, Karen Harutyunyan, Nadica Trajkovska, Philipp Lucas, Thomas Eitz, Maxim Didenko, Philipp Sommer, Christian Sohns   +14 more
wiley   +1 more source

Percutaneous versus open cannulation for mechanical support in patients with right ventricular failure after left ventricular assist device placement [PDF]

Exploration of Cardiology
Aim: Temporary right ventricular assist device (t-RVAD) is an option for those patients in right ventricular failure (RVF) after left ventricular assist device (LVAD) resistant to ionotropic therapy.
Amit Prasad, Anthony Kronfli, Nadia Assiaoui, Christoph Brehm, Behzad Soleimani   +4 more
doaj   +1 more source

The effect of perioperative erythropoietin‐stimulating agents and intravenous iron on patient outcomes following solid organ transplantation: A systematic review

Transfusion Medicine, EarlyView.
Abstract Solid organ transplant is associated with high rates of anaemia and transfusion, but there is little comparative data on interventions such as erythropoietin‐stimulating agents (ESAs) and intravenous (IV) iron. We conducted a systematic review examining the association of ESAs and IV iron with outcomes in adults undergoing solid organ ...
Frank Lee, Quentin Eichbaum, Christine Cserti‐Gazdewich, Darren Mullane, Frederick W. Lombard, Jeremy W. Jacobs, Katerina Pavenski, Marina Englesakis, Alexander Dotto, Terry Cho, Andrés Leonard‐Reixa, Jacqueline Trudeau, Andrew W. Shih, Justyna Bartoszko   +13 more
wiley   +1 more source

The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients

Biomedical Papers, 2016
Aims: One of the proposed limitations of left ventricular assist device (LVAD) therapy is high degree of sensitization. Apart from human leukocyte antigen (HLA), antibodies against Angiotensin II Type 1 Receptor (AT1R) have been associated with adverse ...
Marian Urban, Antonij Slavcev, Tomas Gazdic, Peter Ivak, Ivan Netuka   +4 more
doaj   +1 more source